Santarus Clinical Investigational Site 1064 — Lancaster, Pennsylvania

Santarus Clinical Investigational Site 1064 is a clinical research site located in Lancaster, Pennsylvania, United States 17604.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Santarus Clinical Investigational Site 1064 has participated in 1 clinical trials.

Therapeutic areas: Ulcerative Colitis.

Sponsors: Bausch Health Americas, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Santarus Clinical Investigational Site 1064?

Santarus Clinical Investigational Site 1064 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Santarus Clinical Investigational Site 1064 conducted?

Santarus Clinical Investigational Site 1064 has 1 clinical trials on record. Their work covers Ulcerative Colitis.

Is Santarus Clinical Investigational Site 1064 accredited by Crixeo Health?

Santarus Clinical Investigational Site 1064 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Santarus Clinical Investigational Site 1064?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.